ES2058460T3 - Preparado para la prevencion y el tratamiento de la osteoporosis. - Google Patents

Preparado para la prevencion y el tratamiento de la osteoporosis.

Info

Publication number
ES2058460T3
ES2058460T3 ES89123731T ES89123731T ES2058460T3 ES 2058460 T3 ES2058460 T3 ES 2058460T3 ES 89123731 T ES89123731 T ES 89123731T ES 89123731 T ES89123731 T ES 89123731T ES 2058460 T3 ES2058460 T3 ES 2058460T3
Authority
ES
Spain
Prior art keywords
osteoporosis
prevention
prepared
treatment
appropriate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89123731T
Other languages
English (en)
Inventor
Jozsef Dr Markus
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2058460T3 publication Critical patent/ES2058460T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/42Phosphorus; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Soil Conditioners And Soil-Stabilizing Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

EL INVENTO SE REFIERE A UN PRODUCTO PARA EL TRATAMIENTO DE LA ANOSTOSIS, QUE SE COMPONE DE: 20-45 % DE HARINA DE CALCITA, 10-20 % DE HARINA DE DOLOMITA, 30-60 % DE BIFOSFATO CALCICO, EVENTUALMENTE, MAXIMO 6 % DE MEZCLA PREVIA DE MICROELEMENTOS Y EVENTUALMENTE, MAXIMO 5 % DE ADITIVOS CONOCIDOS. TAMBIEN TIENE POR OBJETO UN PRODUCTO PARA LA PREVENCION DE LA ANOSTOSIS, QUE SE COMNPONE DE: 40-60 % DE HARINA DE CALCITA, 40-60 % DE HARINA DE DOLOMITA Y, EVENTUALMENTE, MAXIMO 6 % DE MEZCLA PREVIA DE MICROELEMENTOS.
ES89123731T 1988-12-22 1989-12-22 Preparado para la prevencion y el tratamiento de la osteoporosis. Expired - Lifetime ES2058460T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU886573A HU200933B (en) 1988-12-22 1988-12-22 Process for producing pharmaceutical composition for profilacting and treating osteoporosis

Publications (1)

Publication Number Publication Date
ES2058460T3 true ES2058460T3 (es) 1994-11-01

Family

ID=10971820

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89123731T Expired - Lifetime ES2058460T3 (es) 1988-12-22 1989-12-22 Preparado para la prevencion y el tratamiento de la osteoporosis.

Country Status (5)

Country Link
EP (1) EP0374935B1 (es)
AT (1) ATE91080T1 (es)
DE (1) DE58904841D1 (es)
ES (1) ES2058460T3 (es)
HU (1) HU200933B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3053301B2 (ja) * 1992-09-11 2000-06-19 三菱電機株式会社 半導体集積回路及びicカード
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
AT408416B (de) * 1996-07-19 2001-11-26 Norbert Fuchs Pharmazeutische bzw. diätetische zusammensetzungen
DE10323759A1 (de) * 2003-05-22 2004-12-16 Bauer, Wulf, Dr. Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2226273C2 (de) * 1972-05-30 1982-12-30 Rotta Research Laboratorium S.p.A., San Fruttuoso di Monza, Milano Präparate zur Behandlung der Osteoporose

Also Published As

Publication number Publication date
HU200933B (en) 1990-09-28
EP0374935A1 (de) 1990-06-27
EP0374935B1 (de) 1993-06-30
ATE91080T1 (de) 1993-07-15
DE58904841D1 (de) 1993-08-05

Similar Documents

Publication Publication Date Title
EP0386757A3 (en) Biodegradable poly (phosphate esters)
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
HU9402342D0 (en) Phosphono-oxymethyl-ethers of taxane derivatives
DE69322765D1 (de) Carbonierte hydroxyapatit-zusammensetzungen und ihre verwendungen
ES2060883T3 (es) Procedimiento de obtencion del acido carnosico.
GR3006630T3 (es)
IL86951A0 (en) Methylene phosphonoalkylphosphinates and pharmaceutical compositions containing them
ZA943744B (en) Therapeutic substituted guanidines
HK1120211A1 (en) Agents and methods for protection, treatment and repair of connective tissue
BG99177A (en) New 7 -substituted-4-aza-5 - cholestanones as inhibitors of 5 - reductase
TR22328A (tr) Laklarin,mumlarin ve sivama maddelerinin pihtilastirilmasina mahsus madde
NZ224708A (en) Furanone derivatives and anti-inflammatory compositions
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
GR3006636T3 (es)
ES2058460T3 (es) Preparado para la prevencion y el tratamiento de la osteoporosis.
ES2099865T3 (es) Ciclopentanoperhidrofenantreno-17beta-(3-furil)-3-derivados y composiciones farmaceuticas que comprenden los mismos para el tratamiento de trastornos cardiovasculares.
EP0340391A3 (en) 1,4-disubstituted-2,3,4,6-tetrahydroxy-1,4-diphosphorinane and their oxides or sulfides
PH27352A (en) 4-Benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
TW277050B (es)
GR3017358T3 (en) 5-Aryl-3H-1,2,4-triazol-3-ones and their use as anticonvulsants.
ZA922899B (en) Pharmaceutical compositions
GB2346146A (en) Calcineurin-dependent control of skeletal muscle fiber type
GR3017350T3 (en) 2-Alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia.
MY108690A (en) Mildewproofing agent for timber
UA23061A (uk) Композиція для лікуваhhя і профілактики ектопаразитарhих хвороб твариh

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 374935

Country of ref document: ES